IHH Healthcare Berhad | Annual Report 2024 90 The NRC meetings were attended by the Group Chief Executive Officer, relevant personnel of Human Resources functions, other members of the Senior Management, and professional advisors engaged on particular subject matters, upon invitation by the NRC. Minutes of the NRC meetings were circulated to all members for comments, and the decisions made by the NRC were communicated to the relevant process owners for action. The Chairman of the NRC provided a report highlighting significant points of the decisions and recommendations made by the NRC to the Board, as well as significant matters reserved for the Board’s approval, if any. Summary of Activities During the financial year under review, the NRC carried out, among others, the following key activities: 1. Assessed and recommended to the Board, the composition of the Board of Directors and Board Committees of the Company as well as Board of Directors of the subsidiaries; 2. Assessed and recommended to the Board, the appointment of new Directors; 3. Assessed and recommended to the Board for consideration, the re-election of Directors at the Fourteenth Annual General Meeting (AGM); 4. Assessed the Board and Board Committees’ composition, performance, quality, skills, competencies, effectiveness for the year 2023 and training needs of Directors as well as discussed the annual evaluation outcomes of the Board, Board Committees and individual Directors; 5. Assessed the performance and achievement of the key performance indicators of the Group for 2023 against the approved balanced scorecard (BSC); 6. Deliberated and recommended to the Board for approval, the BSC framework of the Group for the years 2024 and 2025, taking into account the Group’s sustainability strategies, priorities and targets; 7. Reviewed the Non-Executive Directors fees from 1 July 2024 until 30 June 2025; 8. Discussed and recommended to the Board for approval, the establishment of share-based long-term incentive plans for the eligible employees of the Group; 9. Discussed and recommended to the Board for approval, the bonus and salary increment (where applicable) for the Group for year 2023 and 2024 respectively and long term incentive for selected Senior Management of the Group upon assessing the performance of the Group for year 2023 and individual performance appraisal; 10. Discussed and recommended to the Board for approval, the implementation of the retention plans for selected roles in the Group’s key markets; 11. Reviewed and recommended to the Board for approval, the NRC Report for inclusion in the Annual Report 2023; 12. Reviewed and recommended to the Board for approval, the appointment and employment contract renewal, where applicable, of the relevant Senior Management members; 13. Discussed the succession planning of key positions of the Group; 14. Discussed and recommended to the Board for approval, the revision of medical benefits for Non-Executive Directors; and 15. Reviewed and recommended to the Board for approval, the 2025 Business Critical Roles framework. Selection and Appointment of Directors The Group has adopted the Policy on the Nomination and Assessment Process of Board Members (Policy on Nomination and Assessment) which outlines the process and requirements for NRC and Board to fulfil their duties regarding the nomination, assessment and re-election of Board members in compliance with the Main Market Listing Requirements (MMLR) of Bursa Malaysia Securities Berhad and Malaysian Code on Corporate Governance (MCCG). The NRC is responsible for administering this Policy on Nomination and Assessment. Nomination and Remuneration Committee Report Governance
RkJQdWJsaXNoZXIy NDgzMzc=